We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
RBC
1226
Romano Brothers & Co
Illinois
$5.33M -$38.4K -258 -0.7%
SEEDPG
1227
S.E.E.D. Planning Group
New York
$5.33M +$460K +3,094 +9%
BFW
1228
Brady Family Wealth
Missouri
$5.32M -$421K -2,831 -7%
CI
1229
CX Institutional
Indiana
$5.31M -$549K -3,693 -9%
NAM
1230
NTV Asset Management
West Virginia
$5.3M +$41.3K +278 +0.8%
SIA
1231
Soltis Investment Advisors
Utah
$5.29M +$91.2K +613 +2%
MSFS
1232
Main Street Financial Solutions
Pennsylvania
$5.28M +$134K +900 +3%
LI
1233
Louisbourg Investments
New Brunswick, Canada
$5.28M +$461K +3,100 +7%
AFA
1234
AllGen Financial Advisors
Florida
$5.27M +$661K +4,443 +14%
FC
1235
Fusion Capital
South Carolina
$5.27M +$60.1K +404 +1%
MAS
1236
Meeder Advisory Services
Ohio
$5.27M +$1.04M +7,020 +24%
JCM
1237
Jacobi Capital Management
Pennsylvania
$5.27M -$446 -3 -0%
DLCIG
1238
D.L. Carlson Investment Group
New Hampshire
$5.26M -$66K -444 -1%
MSAM
1239
Moloney Securities Asset Management
Missouri
$5.26M +$152K +1,020 +3%
SCP
1240
Shorepoint Capital Partners
Massachusetts
$5.26M +$38.7K +260 +0.7%
EDRH
1241
Edmond de Rothschild Holding
Switzerland
$5.26M -$4.31M -29,005 -45%
MFG
1242
Monte Financial Group
Connecticut
$5.26M +$852K +5,731 +19%
PIM
1243
Platinum Investment Management
Australia
$5.25M -$576K -3,871 -10%
KP
1244
Keel Point
Alabama
$5.25M +$267K +1,794 +6%
SP
1245
Stablepoint Partners
Massachusetts
$5.24M +$336K +2,262 +7%
IAN
1246
Integrated Advisors Network
Texas
$5.24M -$261K -1,758 -5%
ST
1247
Somerset Trust
Pennsylvania
$5.23M +$46K +309 +0.9%
QOP
1248
Quinn Opportunity Partners
Virginia
$5.19M +$1.86M +12,500 +54%
NPT
1249
National Philanthropic Trust
Pennsylvania
$5.18M -$121K -814 -2%
SF
1250
Symphony Financial
Texas
$5.18M +$2.6M +17,498 +97%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.